Page last updated: 2024-09-04
bw 58c and nadp
bw 58c has been researched along with nadp in 1 studies
Compound Research Comparison
| Studies (bw 58c) | Trials (bw 58c) | Recent Studies (post-2010) (bw 58c) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 21,608 | 25 | 3,484 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dickins, M; Ginger, CD; Gutteridge, WE; Holdich, T; Hudson, AT; Hutchinson, DB; Latter, VS; Pudney, M; Randall, AW | 1 |
Other Studies
1 other study(ies) available for bw 58c and nadp
| Article | Year |
|---|---|
566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Infective Agents; Antimalarials; Aotus trivirgatus; Atovaquone; Dogs; Humans; Malaria, Falciparum; Male; Microsomes, Liver; Middle Aged; NADP; Naphthoquinones; Opportunistic Infections; Plasmodium; Rats; Toxoplasma | 1991 |